Printer Friendly

EPIGEN REPORTS SECOND QUARTER FINANCIAL RESULTS; COMPANY SCIENTISTS TO PRESENT DATA AT INTERNATIONAL GLYCOCONJUGATE SYMPOSIUM

 WELLESLEY, Mass., Aug. 10 /PRNewswire/ -- Epigen, Inc. (AMEX-ECM: EPN.EC), a biopharmaceutical company organized to develop and commercialize cancer diagnostics, imaging agents and therapeutics, today announced financial results for the six-month period ended June 30, 1993. The net loss for the period was $1,153,153 ($0.34 per share) compared to a net loss of $768,548 ($0.21 per share) in the similar period of the previous year.
 James Mongiardo, president and CEO of Epigen, announced, "Epigen has started its preclinical trials for the COD Test. This product is an in vitro (outside the body) blood test designed for use as a monitoring aid for carcinoma patients. The company is making significant progress toward the commercialization of all its unique cancer products. This includes a new program to commercialize a tissue staining test which will differentiate cancerous from benign prostate tissue. The company expects to have this product on the market in the fourth quarter."
 Mr. Mongiardo also announced that two of its scientific advisory board members, Dr. John Codington, Harvard Medical School, and Dr. Svein Haavik, University of Oslo, will be presenting data at the XII International Symposium of Glycoconjugates in Krakow, Poland August 15- 20.
 Dr. Haavik will present data on the structure of Epigen's Human Carcinoma Antigen (HCA) which is the basis of the company's products. Company research has shown that HCA is shed into the bloodstream in an amount correlating to tumor burden. Dr. Codington will present data on Epigen's COD Test which measures the amount of HCA in the bloodstream.
 -0- 8/10/93
 /CONTACT: James F. Mongiardo, president of Epigen, Inc., 617-237-9102, or William Doyle of Strategic Marketing Systems, 212-230-2177/
 (EPN.EC)


CO: Epigen, Inc. ST: Massachusetts IN: MTC SU: ERN

LD-TM -- NY002 -- 1051 08/10/93 08:50 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 10, 1993
Words:298
Previous Article:CII FINANCIAL INC. REPORTS FURTHER IMPROVEMENT FOR SECOND QUARTER
Next Article:IN-STORE ADVERTISING, INC. COMPLETES CHAPTER 11 REORGANIZATION ANNOUNCES NAME CHANGE TO EMARC, INC.
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters